Compare Galenica AG with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.58%
0%
-18.58%
6 Months
-5.18%
0%
-5.18%
1 Year
-3.68%
0%
-3.68%
2 Years
15.24%
0%
15.24%
3 Years
8.14%
0%
8.14%
4 Years
13.66%
0%
13.66%
5 Years
28.45%
0%
28.45%
Galenica AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.51%
EBIT Growth (5y)
1.61%
EBIT to Interest (avg)
28.99
Debt to EBITDA (avg)
1.41
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
2.01
Tax Ratio
14.83%
Dividend Payout Ratio
68.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.84%
ROE (avg)
13.33%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
3.19
EV to EBIT
24.18
EV to EBITDA
15.98
EV to Capital Employed
2.45
EV to Sales
1.33
PEG Ratio
25.70
Dividend Yield
2.43%
ROCE (Latest)
10.13%
ROE (Latest)
12.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
3,921.10
3,746.00
4.67%
Operating Profit (PBDIT) excl Other Income
311.20
288.30
7.94%
Interest
13.10
15.80
-17.09%
Exceptional Items
10.60
10.10
4.95%
Consolidate Net Profit
183.70
165.70
10.86%
Operating Profit Margin (Excl OI)
51.40%
49.50%
0.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 4.67% vs 4.39% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 10.86% vs 5.34% in Dec 2023
About Galenica AG 
Galenica AG
Retailing
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Company Coordinates 
Company Details
Untermattweg 8 , BERN None : 3027
Registrar Details






